🧪 Pancreatic Amylase Test
🧪 Pancreatic Amylase Test: Complete Guide
Key Enzyme for Acute Pancreatitis · Enzymatic Assay · Reference Range · Clinical Interpretation
Pancreatic amylase (P-AMY) is a digestive enzyme responsible for the breakdown of carbohydrates.
Amylase exists in two major isoforms:
- Pancreatic type (P-AMY) – produced by pancreatic acinar cells
- Salivary type (S-AMY) – produced by salivary glands
Because P-AMY originates directly from the pancreas, it serves as a highly specific marker for diseases involving the pancreas and pancreatic ducts, especially acute pancreatitis.
1. Clinical Purpose of the Test
① Diagnosis of Acute Pancreatitis
- Rises rapidly within hours after symptom onset
- Peaks within 24 hours
- Returns to normal within 3–5 days
Useful in early phase but normalizing quickly can limit later diagnostic value.
② Evaluation of acute flare-ups in chronic pancreatitis
Both chronic damage and acute inflammatory episodes may elevate P-AMY.
③ Differentiation of elevated total amylase
Isoenzyme separation helps distinguish:
- Salivary gland disease (↑ S-AMY)
- Pancreatic disease (↑ P-AMY)
④ Assessment of biliary and pancreatic duct obstruction
Obstruction caused by:
- Gallstones
- Tumors
- Pancreatic duct strictures
Leads to enzyme leakage into the bloodstream.
⑤ Evaluation of amylase elevation in renal failure
Since renal clearance is decreased, identifying P-AMY dominance can guide interpretation.
2. Test Method: Enzymatic Kinetic Assay
Most laboratories use enzymatic kinetic assays for measurement.
🔬 Principle
- Synthetic substrates (e.g., CNPG3, EPS-G7) are hydrolyzed by amylase.
- This multi-step reaction releases a chromophore.
- A spectrophotometer measures the rate of absorbance increase.
- The reaction rate → proportional to amylase activity (U/L).
⚠ Pre-analytical Considerations
- Hemolysis and lipemia may cause analytic interference.
- Confirm timing of sample collection, as amylase levels decline quickly.
- Macroamylasemia → elevated total amylase but normal P-AMY.
3. Reference Range
Reference intervals vary by analyzer and manufacturer.
Pancreatic Amylase: 18 – 53 IU/L
Some laboratories also report the pancreatic fraction (%) of total amylase.
4. Clinical Significance
P-AMY is secreted into the duodenum via the pancreatic duct.
When inflammation, injury, or ductal obstruction occurs, the enzyme leaks into the bloodstream.
Key characteristics
- Rapid rise → useful in early acute pancreatitis
- Rapid normalization → lower sensitivity than lipase in later stages
- Higher specificity compared to total amylase or saliva-dominant amylase
A critical benefit is the ability to distinguish pancreatic vs salivary sources of hyperamylasemia.
5. Conditions Associated with Increased P-AMY (↑)
1) Acute Pancreatitis (most common)
Causes include:
- Alcohol
- Gallstones
- High-fat meals
- Post-ERCP inflammation
Typically ≥3× upper limit of normal.
2) Exacerbation of chronic pancreatitis
3) Pancreatic or biliary duct obstruction
- Choledocholithiasis
- Pancreatic cancer
- Pseudocyst
- Sphincter of Oddi dysfunction
4) Other abdominal diseases
- Bowel obstruction
- Perforated peptic ulcer
- Mesenteric ischemia
5) Renal failure
Reduced clearance → elevated enzyme levels
6) Miscellaneous
- ERCP
- Combined rise of salivary isoenzyme
- Macroamylasemia (total amylase ↑, P-AMY normal)
6. Conditions Associated with Decreased P-AMY (↓)
Less clinically significant but may indicate reduced pancreatic exocrine function:
- Chronic pancreatitis (advanced)
- Cystic fibrosis
- Post-pancreatectomy
7. Interpretation Tips
- Lipase is more sensitive and remains elevated longer
→ best practice: interpret P-AMY together with lipase. - Normal P-AMY does not exclude pancreatitis
Especially in:- Alcoholic pancreatitis
- Hypertriglyceridemia-induced pancreatitis
- Lipemic samples can cause falsely low results
- Macroamylasemia
- Total amylase ↑
- P-AMY normal → useful differentiation
- Renal impairment may cause false elevations
- Timing is crucial
- Early stage: elevated
- After 3–5 days: may normalize
NAG (N-Acetyl-β-D-Glucosaminidase) Test – MedLab Insight
8. Summary Table
| Item | Description |
|---|---|
| Test Name | Pancreatic Amylase |
| Purpose | Diagnose acute/chronic pancreatitis, ductal obstruction |
| Method | Enzymatic kinetic assay |
| Reference Range | 18–53 U/L |
| Increased In | Acute pancreatitis, gallstones, duct obstruction, renal failure |
| Decreased In | Chronic pancreatitis, cystic fibrosis |
| Key Point | Best interpreted alongside lipase |
References
- Tietz Textbook of Clinical Chemistry & Molecular Diagnostics, 6th ed.
- Henry’s Clinical Diagnosis and Management by Laboratory Methods, 24th ed.
- Banks PA. Acute pancreatitis classification. Am J Gastroenterol.
- Clinical usefulness of pancreatic amylase isoenzymes. Clin Chim Acta.
- Management guidelines for acute pancreatitis. World J Gastroenterol.
- Evaluation of serum amylase and lipase in pancreatitis. Clin Biochem.